{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:18:33Z","timestamp":1792498713175,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T00:00:00Z","timestamp":1607644800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s12325-020-01557-x","type":"journal-article","created":{"date-parts":[[2020,12,11]],"date-time":"2020-12-11T14:05:23Z","timestamp":1607695523000},"page":"835-853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effects of Tiotropium\/Olodaterol on Activity-Related Breathlessness, Exercise Endurance and Physical Activity in Patients with COPD: Narrative Review with Meta-\/Pooled Analyses"],"prefix":"10.1007","volume":"38","author":[{"given":"Fran\u00e7ois","family":"Maltais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"de la Hoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Casaburi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"O\u2019Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,11]]},"reference":[{"issue":"7","key":"1557_CR1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.rmed.2010.01.012","volume":"104","author":"T Troosters","year":"2010","unstructured":"Troosters T, Sciurba F, Battaglia S, et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med. 2010;104(7):1005\u201311.","journal-title":"Respir Med"},{"issue":"2 Suppl","key":"1557_CR2","first-page":"S3","volume":"67","author":"N Marchetti","year":"2018","unstructured":"Marchetti N, Kaplan A. COPD in primary care: key considerations for optimized management: dyspnea and hyperinflation in chronic obstructive pulmonary disease: impact on physical activity. J Fam Pract. 2018;67(2 Suppl):S3\u201310.","journal-title":"J Fam Pract"},{"key":"1557_CR3","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2147\/COPD.S188141","volume":"14","author":"NA Hanania","year":"2019","unstructured":"Hanania NA, O\u2019Donnell DE. Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions. Int J Chronic Obstr Pulm Dis. 2019;14:1127\u201338.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"1557_CR4","doi-asserted-by":"crossref","unstructured":"Dekhuijzen R, Hass N, Liu J, Dreher M. Daily impact of COPD in younger and older adults: global online survey results from over 1300 patients. COPD. 2020;17(4):419\u201328.","DOI":"10.1080\/15412555.2020.1788526"},{"issue":"2","key":"1557_CR5","doi-asserted-by":"crossref","first-page":"1701477","DOI":"10.1183\/13993003.01477-2017","volume":"51","author":"A Hutchinson","year":"2018","unstructured":"Hutchinson A, Barclay-Klingle N, Galvin K, Johnson MJ. Living with breathlessness: a systematic literature review and qualitative synthesis. Eur Respir J. 2018;51(2):1701477.","journal-title":"Eur Respir J"},{"issue":"3","key":"1557_CR6","doi-asserted-by":"crossref","first-page":"1800079","DOI":"10.1183\/13993003.00079-2018","volume":"52","author":"MA Ramon","year":"2018","unstructured":"Ramon MA, Ter Riet G, Carsin AE, et al. The dyspnoea-inactivity vicious circle in COPD: development and external validation of a conceptual model. Eur Respir J. 2018;52(3):1800079.","journal-title":"Eur Respir J"},{"issue":"1","key":"1557_CR7","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1183\/09031936.00046906","volume":"29","author":"P Palange","year":"2007","unstructured":"Palange P, Ward SA, Carlsen KH, et al. Recommendations on the use of exercise testing in clinical practice. Euro Respir J. 2007;29(1):185\u2013209.","journal-title":"Euro Respir J"},{"issue":"4","key":"1557_CR8","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1513\/pats.201101-001RM","volume":"8","author":"R Casaburi","year":"2011","unstructured":"Casaburi R. Activity promotion: a paradigm shift for chronic obstructive pulmonary disease therapeutics. Proc Am Thorac Soc. 2011;8(4):334\u20137.","journal-title":"Proc Am Thorac Soc"},{"issue":"10","key":"1557_CR9","first-page":"E418","volume":"7","author":"J Gea","year":"2015","unstructured":"Gea J, Pascual S, Casadevall C, Orozco-Levi M, Barreiro E. Muscle dysfunction in chronic obstructive pulmonary disease: update on causes and biological findings. J Thorac Dis. 2015;7(10):E418\u201338.","journal-title":"J Thorac Dis"},{"issue":"5","key":"1557_CR10","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7861\/clinmedicine.9-5-448","volume":"9","author":"J Moxham","year":"2009","unstructured":"Moxham J, Jolley C. Breathlessness, fatigue and the respiratory muscles. Clin Med. 2009;9(5):448\u201352.","journal-title":"Clin Med"},{"issue":"9","key":"1557_CR11","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/thx.2006.060145","volume":"61","author":"J Garcia-Aymerich","year":"2006","unstructured":"Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Ant\u00f3 JM. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax. 2006;61(9):772\u20138.","journal-title":"Thorax"},{"issue":"5","key":"1557_CR12","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1183\/09031936.00151014","volume":"44","author":"R ZuWallack","year":"2014","unstructured":"ZuWallack R, Esteban C. Understanding the impact of physical activity in COPD outcomes: moving forward. Eur Respir J. 2014;44(5):1107\u20139.","journal-title":"Eur Respir J"},{"issue":"2","key":"1557_CR13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1378\/chest.10-2521","volume":"140","author":"B Waschki","year":"2011","unstructured":"Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140(2):331\u201342.","journal-title":"Chest"},{"issue":"1","key":"1557_CR14","doi-asserted-by":"crossref","first-page":"e85540","DOI":"10.1371\/journal.pone.0085540","volume":"9","author":"H Mullerova","year":"2014","unstructured":"Mullerova H, Lu C, Li H, Tabberer M. Prevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary care. PLoS One. 2014;9(1):e85540.","journal-title":"PLoS One"},{"issue":"1","key":"1557_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12890-020-1097-y","volume":"20","author":"AM Albarrati","year":"2020","unstructured":"Albarrati AM, Gale NS, Munnery MM, Cockcroft JR, Shale DJ. Daily physical activity and related risk factors in COPD. BMC Pulm Med. 2020;20(1):1\u20138.","journal-title":"BMC Pulm Med"},{"key":"1557_CR16","unstructured":"Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2020 report). 2019. https:\/\/goldcopd.org\/wp-content\/uploads\/2019\/11\/GOLD-2020-REPORT-ver1.0wms.pdf. Accessed  15 June 2020."},{"issue":"8","key":"1557_CR17","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1164\/rccm.201706-1288OC","volume":"198","author":"T Troosters","year":"2018","unstructured":"Troosters T, Maltais F, Leidy N, et al. Effect of bronchodilation, exercise training, and behavior modification on symptoms and physical activity in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(8):1021\u201332.","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"1557_CR18","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.amjmed.2017.12.018","volume":"131","author":"A Anzueto","year":"2018","unstructured":"Anzueto A, Miravitlles M. The role of fixed-dose dual bronchodilator therapy in treating COPD. Am J Med. 2018;131(6):608\u201322.","journal-title":"Am J Med"},{"key":"1557_CR19","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.2147\/COPD.S170606","volume":"13","author":"P Rogliani","year":"2018","unstructured":"Rogliani P, Calzetta L, Braido F, et al. LABA\/LAMA fixed-dose combinations in patients with COPD: a systematic review. Int J Chronic Obstr Pulm Dis. 2018;13:3115\u201330.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"4","key":"1557_CR20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1183\/09031936.00136014","volume":"45","author":"R Buhl","year":"2015","unstructured":"Buhl R, Maltais F, Abrahams R, et al. Tiotropium and olodaterol fixed-dose combination versus mono-components in COPD (GOLD 2\u20134). Eur Respir J. 2015;45(4):969\u201379.","journal-title":"Eur Respir J"},{"key":"1557_CR21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pupt.2015.04.002","volume":"32","author":"KM Beeh","year":"2015","unstructured":"Beeh KM, Westerman J, Kirsten AM, et al. The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2015;32:53\u20139.","journal-title":"Pulm Pharmacol Ther"},{"issue":"10","key":"1557_CR22","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.rmed.2015.08.002","volume":"109","author":"D Singh","year":"2015","unstructured":"Singh D, Ferguson GT, Bolitschek J, et al. Tiotropium + olodaterol shows clinically meaningful improvements in quality of life. Respir Med. 2015;109(10):1312\u20139.","journal-title":"Respir Med"},{"key":"1557_CR23","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/COPD.S32675","volume":"7","author":"P Jones","year":"2012","unstructured":"Jones P, Miravitlles M, van der Molen T, Kulich K. Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement. Int J Chronic Obstr Pulm Dis. 2012;7:697\u2013709.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"6","key":"1557_CR24","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1164\/rccm.200812-1873OC","volume":"180","author":"F Garcia-Rio","year":"2009","unstructured":"Garcia-Rio F, Lores V, Mediano O, et al. Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med. 2009;180(6):506\u201312.","journal-title":"Am J Respir Crit Care Med"},{"key":"1557_CR25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1465-9921-11-79","volume":"11","author":"T Glaab","year":"2010","unstructured":"Glaab T, Vogelmeier C, Buhl R. Outcome measures in chronic obstructive pulmonary disease (COPD): strengths and limitations. Respir Res. 2010;11:79.","journal-title":"Respir Res"},{"issue":"1","key":"1557_CR26","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4104\/pcrj.2013.00025","volume":"22","author":"M Thomas","year":"2013","unstructured":"Thomas M, Decramer M, O\u2019Donnell DE. No room to breathe: the importance of lung hyperinflation in COPD. Primary Care Respir J. 2013;22(1):101\u201311.","journal-title":"Primary Care Respir J"},{"issue":"6","key":"1557_CR27","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1586\/17476348.2014.949676","volume":"8","author":"D Langer","year":"2014","unstructured":"Langer D, Ciavaglia CE, Neder JA, Webb KA, O\u2019Donnell DE. Lung hyperinflation in chronic obstructive pulmonary disease: mechanisms, clinical implications and treatment. Expert Rev Respir Med. 2014;8(6):731\u201349.","journal-title":"Expert Rev Respir Med"},{"issue":"4","key":"1557_CR28","doi-asserted-by":"crossref","first-page":"1601348","DOI":"10.1183\/13993003.01348-2016","volume":"49","author":"DE O'Donnell","year":"2017","unstructured":"O\u2019Donnell DE, Casaburi R, Frith P, et al. Effects of combined tiotropium\/olodaterol on inspiratory capacity and exercise endurance in COPD. Eur Respir J. 2017;49(4):1601348.","journal-title":"Eur Respir J"},{"key":"1557_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1753465818755091","volume":"12","author":"F Maltais","year":"2018","unstructured":"Maltais F, O\u2019Donnell D, Galdiz Iturri JB, et al. Effect of 12 weeks of once-daily tiotropium\/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease. Ther Adv Respir Dis. 2018;12:1\u201313.","journal-title":"Ther Adv Respir Dis"},{"issue":"3","key":"1557_CR30","doi-asserted-by":"crossref","first-page":"1802049","DOI":"10.1183\/13993003.02049-2018","volume":"53","author":"F Maltais","year":"2019","unstructured":"Maltais F, Aumann JL, Kirsten A-M, et al. Dual bronchodilation with tiotropium\/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD. Eur Respir J. 2019;53(3):1802049.","journal-title":"Eur Respir J"},{"issue":"4","key":"1557_CR31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1590\/S1413-35552008000400002","volume":"12","author":"J Vilar\u00f3","year":"2008","unstructured":"Vilar\u00f3 J, Resqueti VR, Fregonezi GAF. Clinical assessment of exercise capacity in patients with chronic obstructive pulmonary disease. Brazil J Phys Ther. 2008;12(4):249\u201359.","journal-title":"Brazil J Phys Ther"},{"issue":"2","key":"1557_CR32","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1183\/09031936.00099306","volume":"31","author":"M Cazzola","year":"2008","unstructured":"Cazzola M, MacNee W, Martinez FJ, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J. 2008;31(2):416\u201369.","journal-title":"Eur Respir J"},{"issue":"1","key":"1557_CR33","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","volume":"166","author":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories","year":"2002","unstructured":"ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111\u20137.","journal-title":"Am J Respir Crit Care Med"},{"issue":"12","key":"1557_CR34","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1164\/rccm.201508-1653OC","volume":"194","author":"B Celli","year":"2016","unstructured":"Celli B, Tetzlaff K, Criner G, et al. The 6-minute-walk distance test as a chronic obstructive pulmonary disease stratification tool. Insights from the COPD Biomarker Qualification Consortium. Am J Respir Crit Care Med. 2016;194(12):1483\u201393.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1557_CR35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1183\/13993003.00745-2015","volume":"47","author":"L Puente-Maestu","year":"2016","unstructured":"Puente-Maestu L, Palange P, Casaburi R, et al. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J. 2016;47(2):429\u201360.","journal-title":"Eur Respir J"},{"key":"1557_CR36","doi-asserted-by":"crossref","DOI":"10.1002\/9780470743386","volume-title":"Introduction to meta-analysis","author":"M Borenstein","year":"2009","unstructured":"Borenstein M, Hedges L, Higgins J, Rothstein H. Introduction to meta-analysis. Chichester: Wiley; 2009."},{"issue":"6","key":"1557_CR37","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1183\/09031936.04.00116004","volume":"23","author":"DE O'Donnell","year":"2004","unstructured":"O\u2019Donnell DE, Fluge T, Gerken F, et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J. 2004;23(6):832\u201340.","journal-title":"Eur Respir J"},{"issue":"Suppl 1","key":"1557_CR38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.5271\/sjweh.1815","volume":"16","author":"G Borg","year":"1990","unstructured":"Borg G. Psychophysical scaling with applications in physical work and the perception of exertion. Scand J Work Environ Health. 1990;16(Suppl 1):55\u20138.","journal-title":"Scand J Work Environ Health"},{"key":"1557_CR39","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2147\/COPD.S29571","volume":"7","author":"A Hareendran","year":"2012","unstructured":"Hareendran A, Leidy NK, Monz BU, Winnette R, Becker K, Mahler DA. Proposing a standardized method for evaluating patient report of the intensity of dyspnea during exercise testing in COPD. Int J Chronic Obstr Pulm Dis. 2012;7:345\u201355.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"5","key":"1557_CR40","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1093\/occmed\/kqx063","volume":"67","author":"N Williams","year":"2017","unstructured":"Williams N. The Borg Rating of Perceived Exertion (RPE) scale. Occup Med. 2017;67(5):404\u20135.","journal-title":"Occup Med"},{"issue":"4","key":"1557_CR41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3109\/15412555.2012.674164","volume":"9","author":"F Sava","year":"2012","unstructured":"Sava F, Perrault H, Brouillard C, et al. Detecting improvements in dyspnea in COPD using a three-minute constant rate shuttle walking protocol. COPD. 2012;9(4):395\u2013400.","journal-title":"COPD"},{"issue":"5","key":"1557_CR42","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/15412550903156317","volume":"6","author":"H Perrault","year":"2009","unstructured":"Perrault H, Baril J, Henophy S, Rycroft A, Bourbeau J, Maltais F. Paced-walk and step tests to assess exertional dyspnea in COPD. COPD. 2009;6(5):330\u20139.","journal-title":"COPD"},{"issue":"5","key":"1557_CR43","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/ijcp.12142","volume":"67","author":"L Citrome","year":"2013","unstructured":"Citrome L, Ketter TA. When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed. Int J Clin Pract. 2013;67(5):407\u201311.","journal-title":"Int J Clin Pract"},{"issue":"4","key":"1557_CR44","doi-asserted-by":"crossref","first-page":"e010106","DOI":"10.1136\/bmjopen-2015-010106","volume":"6","author":"T Troosters","year":"2016","unstructured":"Troosters T, Bourbeau J, Maltais F, et al. Enhancing exercise tolerance and physical activity in COPD with combined pharmacological and non-pharmacological interventions: PHYSACTO randomised, placebo-controlled study design. BMJ Open. 2016;6(4):e010106.","journal-title":"BMJ Open"},{"issue":"2","key":"1557_CR45","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MCP.0000000000000242","volume":"22","author":"GL Jones","year":"2016","unstructured":"Jones GL. Quality of life changes over time in patients with chronic obstructive pulmonary disease. Curr Opin Pulm Med. 2016;22(2):125\u20139.","journal-title":"Curr Opin Pulm Med"},{"issue":"8","key":"1557_CR46","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1164\/rccm.201309-1634ST","volume":"188","author":"MA Spruit","year":"2013","unstructured":"Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society\/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13\u201364.","journal-title":"Am J Respir Crit Care Med"},{"key":"1557_CR47","first-page":"CD003793","volume":"2","author":"B McCarthy","year":"2015","unstructured":"McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:CD003793.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"1557_CR48","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.rmed.2013.11.011","volume":"108","author":"NK Leidy","year":"2014","unstructured":"Leidy NK, Kimel M, Ajagbe L, Kim K, Hamilton A, Becker K. Designing trials of behavioral interventions to increase physical activity in patients with COPD: insights from the chronic disease literature. Respir Med. 2014;108(3):472\u201381.","journal-title":"Respir Med"},{"key":"1557_CR49","first-page":"27","volume":"9","author":"JL Corhay","year":"2014","unstructured":"Corhay JL, Dang DN, Van Cauwenberge H, Louis R. Pulmonary rehabilitation and COPD: providing patients a good environment for optimizing therapy. Int J Chronic Obstr Pulm Dis. 2014;9:27\u201339.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"5","key":"1557_CR50","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1378\/chest.06-2418","volume":"131","author":"AL Ries","year":"2007","unstructured":"Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP\/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131(5):4S-42S.","journal-title":"Chest"},{"key":"1557_CR51","doi-asserted-by":"crossref","first-page":"3515","DOI":"10.2147\/COPD.S174827","volume":"13","author":"CR Osadnik","year":"2018","unstructured":"Osadnik CR, Loeckx M, Louvaris Z, et al. The likelihood of improving physical activity after pulmonary rehabilitation is increased in patients with COPD who have better exercise tolerance. Int J Chronic Obstr Pulm Dis. 2018;13:3515\u201327.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"3","key":"1557_CR52","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1378\/chest.127.3.809","volume":"127","author":"R Casaburi","year":"2005","unstructured":"Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest. 2005;127(3):809\u201317.","journal-title":"Chest"},{"issue":"1","key":"1557_CR53","doi-asserted-by":"crossref","first-page":"127","DOI":"10.2147\/COPD.S2389","volume":"3","author":"S Kesten","year":"2008","unstructured":"Kesten S, Casaburi R, Kukafka D, Cooper CB. Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients. Int J Chronic Obstr Pulm Dis. 2008;3(1):127\u201336.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"4","key":"1557_CR54","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1055\/s-0035-1556059","volume":"36","author":"J Bourbeau","year":"2015","unstructured":"Bourbeau J, Lavoie KL, Sedeno M. Comprehensive self-management strategies. Semin Respir Crit Care Med. 2015;36(4):630\u20138.","journal-title":"Semin Respir Crit Care Med"},{"key":"1557_CR55","first-page":"891","volume":"11","author":"R Sauer","year":"2016","unstructured":"Sauer R, Hansel M, Buhl R, Rubin RA, Frey M, Glaab T. Impact of tiotropium + olodaterol on physical functioning in COPD: results of an open-label observational study. Int J Chronic Obstr Pulm Dis. 2016;11:891\u20138.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"1557_CR56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2147\/COPD.S14082","volume":"5","author":"H Rau-Berger","year":"2010","unstructured":"Rau-Berger H, Mitfessel H, Glaab T. Tiotropium Respimat\u00ae improves physical functioning in chronic obstructive pulmonary disease. Int J Chronic Obstr Pulm Dis. 2010;5:367\u201373.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"1557_CR57","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2147\/COPD.S195852","volume":"14","author":"KO Steinmetz","year":"2019","unstructured":"Steinmetz KO, Abenhardt B, Pabst S, et al. Assessment of physical functioning and handling of tiotropium\/olodaterol Respimat\u00ae in patients with COPD in a real-world clinical setting. Int J Chronic Obstr Pulm Dis. 2019;14:1441\u201353.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"key":"1557_CR58","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.2147\/COPD.S204388","volume":"14","author":"A Valipour","year":"2019","unstructured":"Valipour A, Tamm M, Koci\u00e1nov\u00e1 J, et al. Improvement of self-reported physical functioning with tiotropium\/olodaterol in Central and Eastern European COPD patients. Int J Chronic Obstr Pulm Dis. 2019;14:2343\u201354.","journal-title":"Int J Chronic Obstr Pulm Dis"},{"issue":"1","key":"1557_CR59","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1081\/COPD-200050666","volume":"2","author":"DA Mahler","year":"2005","unstructured":"Mahler DA, Witek TJ Jr. The MCID of the transition dyspnea index is a total score of one unit. COPD. 2005;2(1):99\u2013103.","journal-title":"COPD"},{"issue":"1","key":"1557_CR60","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1081\/COPD-200050513","volume":"2","author":"PW Jones","year":"2005","unstructured":"Jones PW. St. George\u2019s Respiratory Questionnaire: MCID. COPD. 2005;2(1):75\u20139.","journal-title":"COPD"},{"issue":"1","key":"1557_CR61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1081\/COPD-200050651","volume":"2","author":"HJ Schunemann","year":"2005","unstructured":"Schunemann HJ, Puhan M, Goldstein R, Jaeschke R, Guyatt GH. Measurement properties and interpretability of the Chronic Respiratory disease Questionnaire (CRQ). COPD. 2005;2(1):81\u20139.","journal-title":"COPD"},{"issue":"4","key":"1557_CR62","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1183\/09031936.00063810","volume":"37","author":"MA Puhan","year":"2011","unstructured":"Puhan MA, Chandra D, Mosenifar Z, et al. The minimal important difference of exercise tests in severe COPD. Eur Respir J. 2011;37(4):784\u201390.","journal-title":"Eur Respir J"},{"issue":"9","key":"1557_CR63","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/thx.2007.081208","volume":"63","author":"SJ Singh","year":"2008","unstructured":"Singh SJ, Jones PW, Evans R, Morgan MDL. Minimum clinically important improvement for the incremental shuttle walking test. Thorax. 2008;63(9):775\u20137.","journal-title":"Thorax"},{"issue":"2","key":"1557_CR64","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/thx.2010.146159","volume":"66","author":"V Pepin","year":"2011","unstructured":"Pepin V, Laviolette L, Brouillard C, et al. Significance of changes in endurance shuttle walking performance. Thorax. 2011;66(2):115\u201320.","journal-title":"Thorax"},{"key":"1557_CR65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/thx.54.3.213","volume":"54","author":"SM Revill","year":"1999","unstructured":"Revill SM, Morgan MDL, Singh SJ, Williams J, Hardman AE. The endurance shuttle walk: a new field test for the assessment of endurance capacity in chronic obstructive pulmonary disease. Thorax. 1999;54:213\u201322.","journal-title":"Thorax"},{"issue":"1","key":"1557_CR66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1081\/COPD-200050655","volume":"2","author":"AL Ries","year":"2005","unstructured":"Ries AL. Minimally clinically important difference for the UCSD Shortness of Breath Questionnaire, Borg Scale, and Visual Analog Scale. COPD. 2005;2(1):105\u201310.","journal-title":"COPD"},{"issue":"3","key":"1557_CR67","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.201310-1863PP","volume":"189","author":"PW Jones","year":"2014","unstructured":"Jones PW, Beeh KM, Chapman KR, Decramer M, Mahler DA, Wedzicha JA. Minimal clinically important differences in pharmacological trials. Am J Respir Crit Care Med. 2014;189(3):250\u20135.","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01557-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-020-01557-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-020-01557-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T13:02:32Z","timestamp":1613739752000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-020-01557-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,11]]},"references-count":67,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["1557"],"URL":"https:\/\/doi.org\/10.1007\/s12325-020-01557-x","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,11]]},"assertion":[{"value":"14 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}